CARsgen Therapeutics Holdings Ltd. held its annual general meeting on May 22, 2025. During the meeting, several proposals were voted on. The proposal to receive and adopt the audited consolidated financial statements and reports for the year ended December 31, 2024, was approved. The re-election of Mr. Ronggang XIE as a non-executive director was approved. The re-election of Mr. Huaqing GUO as a non-executive director was approved. The re-election of Dr. Guangmei YAN as an independent non-executive director was approved.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。